Literature DB >> 9844062

Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides?

A C Muller Kobold1, G Mesander, C A Stegeman, C G Kallenberg, J W Tervaert.   

Abstract

Vascular injury in vasculitis may be due to activation of circulating neutrophils resulting in their increased adhesiveness to locally activated endothelium (Shwartzman phenomenon). Previously, we demonstrated up-regulation of endothelial intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in biopsies from patients with ANCA-associated vasculitis. In the present study, we investigated the expression of adhesion molecules (CD11b, ICAM-1, VLA-4, L-selectin) and activation markers (CD66b, CD64, CD63) on circulating neutrophils from patients with ANCA-associated vasculitis in comparison with their expression on cells from healthy volunteers and patients with sepsis. We related these findings to parameters of disease activity. Surface marker expression was determined by using a non-activating whole blood flow cytometric assay. The expression of activation markers, but not the expression of adhesion molecules, was increased on neutrophils from patients with active vasculitis. The expression of CD63 and CD66b on neutrophils correlated with disease activity as determined by the Birmingham Vasculitis Activity Score (BVAS). In contrast to patients with active vasculitis, patients with sepsis showed up-regulation of all markers, including adhesion molecules, suggesting that circulating neutrophils are fully activated in sepsis. We conclude that in ANCA-associated vasculitis, circulating neutrophils are not fully activated, since they do not express increased levels of adhesion molecules as sepsis or in the Shwartzman reaction. These findings are compatible with the concept that in vivo vascular damage in ANCA-associated vasculitides does not occur due to a Shwarzman-like reaction but only after ANCA-induced neutrophil activation at the endothelial cell surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844062      PMCID: PMC1905131          DOI: 10.1046/j.1365-2249.1998.00748.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

1.  Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation.

Authors:  T W Kuijpers; A T Tool; C E van der Schoot; L A Ginsel; J J Onderwater; D Roos; A J Verhoeven
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

Review 2.  Adhesion receptors of the immune system.

Authors:  T A Springer
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

Review 3.  Tissue destruction by neutrophils.

Authors:  S J Weiss
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

4.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

Authors:  R J Falk; R S Terrell; L A Charles; J C Jennette
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Antibodies against granule proteins activate neutrophils in vitro.

Authors:  L A Charles; M L Caldas; R J Falk; R S Terrell; J C Jennette
Journal:  J Leukoc Biol       Date:  1991-12       Impact factor: 4.962

6.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

7.  Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited.

Authors:  L W Argenbright; R W Barton
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

8.  Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre.

Authors:  J W Tervaert; M G Huitema; R J Hené; W J Sluiter; T H The; G K van der Hem; C G Kallenberg
Journal:  Lancet       Date:  1990-09-22       Impact factor: 79.321

9.  CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells.

Authors:  M J Metzelaar; P L Wijngaard; P J Peters; J J Sixma; H K Nieuwenhuis; H C Clevers
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

10.  Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin.

Authors:  E A Wayner; A Garcia-Pardo; M J Humphries; J A McDonald; W G Carter
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

View more
  12 in total

Review 1.  Role of proteinase 3 in activation of endothelium.

Authors:  M E Taekema-Roelvink; C van Kooten; C A Verburgh; M R Daha
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis.

Authors:  M M Boomsma; D J Stearns-Kurosawa; C A Stegeman; E Raschi; P L Meroni; S Kurosawa; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  Antineutrophil cytoplasmic antibody and vasculitis: much more than a disease marker.

Authors:  Vivette D'Agati
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 4.  ANCA-associated vasculitides-lessons from the adult literature.

Authors:  Joannis Vamvakopoulos; Caroline O Savage; Lorraine Harper
Journal:  Pediatr Nephrol       Date:  2010-04-01       Impact factor: 3.714

Review 5.  Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides.

Authors:  Ora Shovman; Boris Gilburd; Gisele Zandman-Goddard; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 6.  ANCA-associated vasculitis: from bench research to novel treatments.

Authors:  Lalit Pallan; Caroline O Savage; Lorraine Harper
Journal:  Nat Rev Nephrol       Date:  2009-05       Impact factor: 28.314

7.  ICAM-1-expressing neutrophils exhibit enhanced effector functions in murine models of endotoxemia.

Authors:  Abigail Woodfin; Martina Beyrau; Mathieu-Benoit Voisin; Bin Ma; James R Whiteford; Peter L Hordijk; Nancy Hogg; Sussan Nourshargh
Journal:  Blood       Date:  2015-12-08       Impact factor: 22.113

8.  Pulmonary Infections in the Elderly Lead to Impaired Neutrophil Targeting, Which Is Improved by Simvastatin.

Authors:  Elizabeth Sapey; Jaimin M Patel; Hannah L Greenwood; Georgia M Walton; Jon Hazeldine; Charendeep Sadhra; Dhruv Parekh; Rachel C A Dancer; Peter Nightingale; Janet M Lord; David R Thickett
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

9.  Decreased CXCR1 and CXCR2 expression on neutrophils in anti-neutrophil cytoplasmic autoantibody-associated vasculitides potentially increases neutrophil adhesion and impairs migration.

Authors:  Nan Hu; Johanna Westra; Abraham Rutgers; Berber Doornbos-Van der Meer; Minke G Huitema; Coen A Stegeman; Wayel H Abdulahad; Simon C Satchell; Peter W Mathieson; Peter Heeringa; Cees G M Kallenberg
Journal:  Arthritis Res Ther       Date:  2011-12-08       Impact factor: 5.156

10.  PR3-ANCA in Wegener's granulomatosis prime human mononuclear cells for enhanced activation via TLRs and NOD1/2.

Authors:  Akiko Uehara; Tadasu Sato; Atsushi Iwashiro; Sou Yokota
Journal:  Diagn Pathol       Date:  2009-07-14       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.